title: Influence of CYP2D6*2 and CYP2D6*4 alleles on phenotype in polymedicated depressed inpatients: therapeutic consequences?
authors.forename: E
authors.initials: E
authors.lastname: Haffen
authors.forename: P
authors.initials: P
authors.lastname: Vandel
authors.forename: G
authors.initials: G
authors.lastname: Paintaud
authors.forename: F
authors.initials: F
authors.lastname: Broly
authors.forename: S
authors.initials: S
authors.lastname: Vandel
authors.forename: B
authors.initials: B
authors.lastname: Bonin
authors.forename: P
authors.initials: P
authors.lastname: Bizouard
authors.forename: D
authors.initials: D
authors.lastname: Sechter
authors.forename: P R
authors.initials: PR
authors.lastname: Bechtel
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000483:Alleles; D000928:Antidepressive Agents / Q000378:metabolism* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000378:metabolism* / Q000627:therapeutic use; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism; D003866:Depressive Disorder / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D005260:Female; D005838:Genotype; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D019389:Cytochrome P-450 CYP2D6